 | Up a level |
Number of items: 1.
Janni, W. J., Harbeck, N., Sommer, H., Rack, B., Salmen, J., Augustin, D., Simon, W., Jueckstock, J., Wischnik, A., Anneke, K., Melcher, C., Friese, K. and Kiechle, M. (2011). Sequential Treatment with Epirubicin/Cyclophosphamide, Followed by Docetaxel vs. FEC120 in the Adjuvant Treatment of Breast Cancer Patients with Extensive Lymph Node Involvement: Final Survival Analysis of the German ADEBAR Phase Ill Study. Cancer Res., 71. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445